187 related articles for article (PubMed ID: 23825999)
21. Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C.
Romero-Gómez M; Planas R; Ampuero J; Solà R; García-Samaniego J; Diago M; Crespo J; Calleja JL; Turnes J
Aliment Pharmacol Ther; 2013 Jun; 37(11):1065-73. PubMed ID: 23581537
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of response.
Karaca C; Soyer OM; Baran B; Ormeci AC; Gokturk S; Aydin E; Evirgen S; Akyuz F; Demir K; Besisik F; Kaymakoglu S
Antivir Ther; 2013; 18(4):561-6. PubMed ID: 22976528
[TBL] [Abstract][Full Text] [Related]
24. Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection.
Yilmaz E; Baran B; Soyer OM; Onel M; Onel D; Ormeci AC; Gokturk S; Evirgen S; Akyuz F; Demir K; Besisik F; Kaymakoglu S; Karaca C
Clin Gastroenterol Hepatol; 2014 Oct; 12(10):1753-8. PubMed ID: 24582569
[TBL] [Abstract][Full Text] [Related]
25. Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials.
Awad T; Thorlund K; Hauser G; Stimac D; Mabrouk M; Gluud C
Hepatology; 2010 Apr; 51(4):1176-84. PubMed ID: 20187106
[TBL] [Abstract][Full Text] [Related]
26. Comparative efficacy and overall safety of different doses of consensus interferon for treatment of chronic HCV infection: a systematic review and meta-analysis.
Alavian SM; Behnava B; Tabatabaei SV
Eur J Clin Pharmacol; 2010 Nov; 66(11):1071-9. PubMed ID: 20857094
[TBL] [Abstract][Full Text] [Related]
27. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
Manns M; Marcellin P; Poordad F; de Araujo ES; Buti M; Horsmans Y; Janczewska E; Villamil F; Scott J; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
Lancet; 2014 Aug; 384(9941):414-26. PubMed ID: 24907224
[TBL] [Abstract][Full Text] [Related]
28. Treatment of chronic hepatitis delta virus with peg-interferon and factors that predict sustained viral response.
Samiullah S; Bikharam D; Nasreen
World J Gastroenterol; 2012 Oct; 18(40):5793-8. PubMed ID: 23155322
[TBL] [Abstract][Full Text] [Related]
29. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
[TBL] [Abstract][Full Text] [Related]
30. Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b.
Scotto G; Fazio V; Fornabaio C; Tartaglia A; Di Tullio R; Saracino A; Angarano G
Drugs; 2008; 68(6):791-801. PubMed ID: 18416586
[TBL] [Abstract][Full Text] [Related]
31. Peginterferon alfa-2a is superior to peginterferon alfa-2b in the treatment of naïve patients with hepatitis C virus infection: meta-analysis of randomized controlled trials.
Singal AK; Jampana SC; Anand BS
Dig Dis Sci; 2011 Aug; 56(8):2221-6. PubMed ID: 21643737
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.
Tseng PL; Chen TC; Chien YS; Hung CH; Yen YH; Chang KC; Tsai MC; Lin MT; Lee CT; Shen CH; Hu TH
Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377
[TBL] [Abstract][Full Text] [Related]
33. Treatment options for hepatitis delta virus infection.
Heidrich B; Manns MP; Wedemeyer H
Curr Infect Dis Rep; 2013 Feb; 15(1):31-8. PubMed ID: 23242761
[TBL] [Abstract][Full Text] [Related]
34. Interferon-α for patients with chronic hepatitis delta: a systematic review of randomized clinical trials.
Lamers MH; Kirgiz ÖÖ; Heidrich B; Wedemeyer H; Drenth JP
Antivir Ther; 2012; 17(6):1029-37. PubMed ID: 22892440
[TBL] [Abstract][Full Text] [Related]
35. Comparison of peginterferon and interferon in treating Chinese patients with chronic hepatitis C.
Zhao S; Liu E; Yu H; Yang H; Xun M; Xue X; Song J; Xu K; Chu Y
Hepatogastroenterology; 2008; 55(84):1047-54. PubMed ID: 18705326
[TBL] [Abstract][Full Text] [Related]
36. Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.
Flori N; Funakoshi N; Duny Y; Valats JC; Bismuth M; Christophorou D; Daurès JP; Blanc P
Drugs; 2013 Mar; 73(3):263-77. PubMed ID: 23436591
[TBL] [Abstract][Full Text] [Related]
37. Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D.
Gherlan GS; Lazar SD; Culinescu A; Smadu D; Vatafu AR; Popescu CP; Florescu SA; Ceausu E; Calistru PI
Trop Med Infect Dis; 2024 Mar; 9(4):. PubMed ID: 38668534
[TBL] [Abstract][Full Text] [Related]
38. Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review.
Chou R; Hartung D; Rahman B; Wasson N; Cottrell EB; Fu R
Ann Intern Med; 2013 Jan; 158(2):114-23. PubMed ID: 23437439
[TBL] [Abstract][Full Text] [Related]
39. Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-α2a treatment.
Mederacke I; Yurdaydin C; Dalekos GN; Bremer B; Erhardt A; Cakaloglu Y; Yalcin K; Gurel S; Zeuzem S; Zachou K; Bozkaya H; Dienes HP; Manns MP; Wedemeyer H;
Antivir Ther; 2012; 17(2):305-12. PubMed ID: 22293066
[TBL] [Abstract][Full Text] [Related]
40. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
Rosen I; Kori M; Eshach Adiv O; Yerushalmi B; Zion N; Shaoul R
World J Gastroenterol; 2013 Feb; 19(7):1098-103. PubMed ID: 23467199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
